Up a level |
Pozdnyakova, O., Wu, K., Patki, A., Rodig, S. J., Thiele, J. and Hasserjian, R. (2014). High Concordance in Grading Reticulin Fibrosis and Hematopoietic Cellularity in Patients with Myeloproliferative Neoplasms Enrolled on Fedratinib (A JAK2 Inhibitor) Trials. Lab. Invest., 94. S. 371A - 373. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1530-0307
Pozdnyakova, O., Wu, K., Patki, A., Rodig, S. J., Thiele, J. and Hasserjian, R. (2014). High Concordance in Grading Reticulin Fibrosis and Hematopoietic Cellularity in Patients with Myeloproliferative Neoplasms Enrolled on Fedratinib (A JAK2 Inhibitor) Trials. Mod. Pathol., 27. S. 371A - 373. NEW YORK: NATURE PUBLISHING GROUP. ISSN 1530-0285